These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 29482074)

  • 21. Early signaling pathways activated by c-Kit in hematopoietic cells.
    Linnekin D
    Int J Biochem Cell Biol; 1999 Oct; 31(10):1053-74. PubMed ID: 10582339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kit-Shp2-Kit signaling acts to maintain a functional hematopoietic stem and progenitor cell pool.
    Zhu HH; Ji K; Alderson N; He Z; Li S; Liu W; Zhang DE; Li L; Feng GS
    Blood; 2011 May; 117(20):5350-61. PubMed ID: 21450902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PI3 kinase is indispensable for oncogenic transformation by the V560D mutant of c-Kit in a kinase-independent manner.
    Lindblad O; Kazi JU; Rönnstrand L; Sun J
    Cell Mol Life Sci; 2015 Nov; 72(22):4399-407. PubMed ID: 26040420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The D816V mutation of c-Kit circumvents a requirement for Src family kinases in c-Kit signal transduction.
    Sun J; Pedersen M; Rönnstrand L
    J Biol Chem; 2009 Apr; 284(17):11039-47. PubMed ID: 19265199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kit and Scl regulation of hematopoietic stem cells.
    Rojas-Sutterlin S; Lecuyer E; Hoang T
    Curr Opin Hematol; 2014 Jul; 21(4):256-64. PubMed ID: 24857885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Normal and oncogenic forms of the receptor tyrosine kinase kit.
    Lennartsson J; Jelacic T; Linnekin D; Shivakrupa R
    Stem Cells; 2005; 23(1):16-43. PubMed ID: 15625120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Catalytic-dependent and -independent roles of SHP-2 tyrosine phosphatase in interleukin-3 signaling.
    Yu WM; Hawley TS; Hawley RG; Qu CK
    Oncogene; 2003 Sep; 22(38):5995-6004. PubMed ID: 12955078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. KIT-D816V oncogenic activity is controlled by the juxtamembrane docking site Y568-Y570.
    Chaix A; Arcangeli ML; Lopez S; Voisset E; Yang Y; Vita M; Letard S; Audebert S; Finetti P; Birnbaum D; Bertucci F; Aurrand-Lions M; Dubreuil P; De Sepulveda P
    Oncogene; 2014 Feb; 33(7):872-81. PubMed ID: 23416972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The receptor protein tyrosine phosphatase, PTP-RO, is upregulated during megakaryocyte differentiation and Is associated with the c-Kit receptor.
    Taniguchi Y; London R; Schinkmann K; Jiang S; Avraham H
    Blood; 1999 Jul; 94(2):539-49. PubMed ID: 10397721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. c-kit ligand stimulates tyrosine phosphorylation of the c-Cbl protein in human hematopoietic cells.
    Wisniewski D; Strife A; Clarkson B
    Leukemia; 1996 Sep; 10(9):1436-42. PubMed ID: 8751459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel slug-containing negative-feedback loop regulates SCF/c-Kit-mediated hematopoietic stem cell self-renewal.
    Zhang Z; Zhu P; Zhou Y; Sheng Y; Hong Y; Xiang D; Qian Z; Mosenson J; Wu WS
    Leukemia; 2017 Feb; 31(2):403-413. PubMed ID: 27451973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of c-kit receptor dimerization by fluorescence resonance energy transfer.
    Broudy VC; Lin NL; Bühring HJ; Komatsu N; Kavanagh TJ
    Blood; 1998 Feb; 91(3):898-906. PubMed ID: 9446650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A juxtacrine/paracrine loop between C-Kit and stem cell factor promotes cancer stem cell survival in epithelial ovarian cancer.
    Mazzoldi EL; Pavan S; Pilotto G; Leone K; Pagotto A; Frezzini S; Nicoletto MO; Amadori A; Pastò A
    Cell Death Dis; 2019 May; 10(6):412. PubMed ID: 31138788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aldh2 Attenuates Stem Cell Factor/Kit-Dependent Signaling and Activation in Mast Cells.
    Kim DK; Cho YE; Song BJ; Kawamoto T; Metcalfe DD; Olivera A
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31835486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aberrant autophosphorylation of c-Kit receptor in canine mast cell tumor cell lines.
    Takeuchi Y; Fujino Y; Watanabe M; Nakagawa T; Ohno K; Sasaki N; Sugano S; Tsujimoto H
    Vet Immunol Immunopathol; 2010 Oct; 137(3-4):208-16. PubMed ID: 20591500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Establishment and characterization of pro-B cell lines from motheaten mutant mouse defective in SHP-1 protein tyrosine phosphatase.
    Miyamoto A; Kunisada T; Yamazaki H; Miyake K; Nishikawa SI; Sudo T; Shultz LD; Hayashi SI
    Immunol Lett; 1998 Sep; 63(2):75-82. PubMed ID: 9761368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Signaling by Kit protein-tyrosine kinase--the stem cell factor receptor.
    Roskoski R
    Biochem Biophys Res Commun; 2005 Nov; 337(1):1-13. PubMed ID: 16129412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of hematopoietic stem cells by the steel factor/KIT signaling pathway.
    Kent D; Copley M; Benz C; Dykstra B; Bowie M; Eaves C
    Clin Cancer Res; 2008 Apr; 14(7):1926-30. PubMed ID: 18381929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PRL2/PTP4A2 phosphatase is important for hematopoietic stem cell self-renewal.
    Kobayashi M; Bai Y; Dong Y; Yu H; Chen S; Gao R; Zhang L; Yoder MC; Kapur R; Zhang ZY; Liu Y
    Stem Cells; 2014 Jul; 32(7):1956-67. PubMed ID: 24753135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activating mutation in the catalytic domain of c-kit elicits hematopoietic transformation by receptor self-association not at the ligand-induced dimerization site.
    Tsujimura T; Hashimoto K; Kitayama H; Ikeda H; Sugahara H; Matsumura I; Kaisho T; Terada N; Kitamura Y; Kanakura Y
    Blood; 1999 Feb; 93(4):1319-29. PubMed ID: 9949175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.